Searching On:

Drug:

Vectibix

       
View:
Expand Collapse Vectibix  - General Description panitumumab
A human monoclonal antibody produced in transgenic mice that attaches to the transmembrane epidermal growth factor (EGF) receptor. Panitumumab may inhibit autocrine EGF stimulation of tumor cells that express the EGF receptor, thereby inhibiting tumor cell proliferation.
Drug Code Name
ABX-EGF
Drug Short Name
MOAB ABX-EGF
Synonyms
clone E7.6.3
monoclonal antibody ABX-EGF
US Brand Names
Vectibix
panitumumab
A human monoclonal antibody produced in transgenic mice that attaches to the transmembrane epidermal growth factor (EGF) receptor. Panitumumab may inhibit autocrine EGF stimulation of tumor cells that express the EGF receptor, thereby inhibiting tumor cell proliferation.
Drug Code Name
ABX-EGF
Drug Short Name
MOAB ABX-EGF
Synonyms
clone E7.6.3
monoclonal antibody ABX-EGF
US Brand Names
Vectibix

Share with your Physican

Print information for your Physician.

Print information

Your Matched Clinical Trials

Trial Matches: (D) - Drug
Trial Status: No record found.
Protocol # Title Location Status Match
MGH has many open clinical trials for other cancers not shown on the Targeted Cancer Care website. They can be found on the MassGeneral.org clinical trials search page.

Additional clinical trials may be applicable to your search criteria, but they may not be available at MGH. These clinical trials can typically be found by searching the clinicaltrials.gov website.
There are currently no clinical trials available for your selection. New clinical trials are being approved every day. Please continue to check back for updates.
Trial Status: No record found.

Share with your Physican

Print information for your Physician.

Print information